An open label randomized controlled trial on the preemptive risedronate intervention for renal transplant patients receiving glucocorticoid
Not Applicable
- Conditions
- Bone disease in renal transplant patients receiving glucocorticoid
- Registration Number
- JPRN-C000000391
- Lead Sponsor
- Department of Advanced Technology for Transplantation, Osaka University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1. Previous history of bisphosphonate treatment and/or hormone replacement therapy within one year before entry 2. Contraindication for risedronate or active vitamin D 3. Not suitable to the clinical trial as judged by a physician
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in bone mineral density and bone turnover markers at two-year interval
- Secondary Outcome Measures
Name Time Method Ca, iP, PTH, and indices of renal function. Safety.